Therapeutics
Other Neurotransmitters
- Study completed / Planned end date
- Planned end date unavailable
- Study aborted
Other Neurotransmitters | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BI 409306 |
Phase 2
|
||||||||||||||
BI 425809 |
Phase 2
|
||||||||||||||
Brexpiprazole |
Phase 3
|
||||||||||||||
Dexpramipexole |
Phase 2
|
||||||||||||||
Guanfacine |
Phase 3
|
||||||||||||||
Idalopirdine |
Phase 2, Phase 3
|
||||||||||||||
Intepirdine |
Phase 2, Phase 3
|
||||||||||||||
Masupirdine |
Phase 2
|
||||||||||||||
ORM-12741 |
Phase 2
|
||||||||||||||
PF-05212377 |
Phase 2
|
||||||||||||||
Piromelatine |
Phase 2
|
||||||||||||||
Riluzole |
Phase 2
|
||||||||||||||
VY-AADC |
Phase 1
|